This ticker has not been starred yet CERS Cerus Corp
Surgical & Medical Instruments & Apparatus
Book value per $ invested $ 0.18
Leverage 71.36%
Market Cap $ 308.2m
PE 0.00
Dividend Yield 0.00%
Profit $ -19.7m
Margin -45.30%

Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in Concord, California.

Subscribe Now For Access - Only $1.99 Per Month